---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-044594"
form_type: "8-K"
ticker: "CLSDQ"
cik: "0001539029"
company_name: "Clearside Biomedical, Inc."
filed_at: "2024-04-16T23:59:59+00:00"
generated_at: "2026-06-03T22:13:50.275056+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Clearside Biomedical appoints Anthony S. Gibney to its Board of Directors

## Summary
- Mr. Gibney appointed as a Class III director effective April 15, 2024; term runs through 2025 annual meeting.
- He brings over 25 years biotech experience including Iveric Bio, Achillion, and Leerink Partners.
- Received an option to purchase 45,000 shares of CLSD common stock vesting over 36 months.
- Entitled to $40,000 annual retainer plus additional annual option grants for continuous service.

## SEC filing metadata
- accession: 0000950170-24-044594
- form_type: 8-K
- ticker: CLSDQ
- cik: 0001539029
- company_name: Clearside Biomedical, Inc.
- filed_at: 2024-04-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1539029/000095017024044594/0000950170-24-044594-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1539029/000095017024044594/clsd-20240415.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-044594
- JSON: https://secwatch.observer/filing/0000950170-24-044594.json
- Plain text: https://secwatch.observer/filing/0000950170-24-044594.txt

## Key facts
- Executive change
  Anthony S. Gibney was appointed as Director at Clearside Biomedical, Inc..
  - Action: appointed
  - Role: Director
  source text: On April 15, 2024, the Board of Directors (the “ Board ”) of Clearside Biomedical, Inc. (the “ Company ”) appointed Anthony S. Gibney to serve as a director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1539029/000095017024044594/0000950170-24-044594-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.